AstraZeneca (AZNCF) Institutional Ownership $168.24 -0.04 (-0.02%) As of 10/23/2025 02:36 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartDividendFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestBuy This Stock Institutional Ownership Changes (13F Filings) for AstraZeneca (OTCMKTS:AZNCF)CurrentInstitutional OwnershipPercentage40.87%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$10.94M Get AZNCF Insider Trade Alerts Want to know when executives and insiders are buying or selling AstraZeneca stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data AZNCF Institutional Buying and Selling by Quarter AstraZeneca Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/22/2025Boston Common Asset Management LLC182,435$25.30M0.7%-1.9%0.000% 4/3/2025Boston Common Asset Management LLC185,930$27.01M0.8%-14.2%0.000% 1/15/2025Boston Common Asset Management LLC216,775$28.26M0.8%-17.3%0.000% 10/22/2024Eagle Bay Advisors LLC1,001$156K0.1%N/A0.000% 10/9/2024Boston Common Asset Management LLC262,273$40.77M1.1%-9.2%0.000% 7/8/2024Boston Common Asset Management LLC288,790$45.11M1.2%-3.6%0.000% 5/16/2024Kennedy Capital Management LLC37,554$5.07M0.1%N/A0.000% 1/9/2024Boston Common Asset Management LLC301,010$40.58M0.9%-2.8%0.000% 10/11/2023Boston Common Asset Management LLC309,762$41.97M1.0%-1.1%0.000% 7/24/2023Boston Common Asset Management LLC313,065$44.88M1.0%+15.5%0.000% 5/17/2023Boston Common Asset Management LLC271,130$37.65M0.8%N/A0.000% 5/1/2023Vigilant Capital Management LLC647$90K0.0%-16.2%0.000% (Data available from 1/1/2016 forward) AZNCF Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AZNCF shares? During the previous two years, the following institutional investors and hedge funds held shares of AstraZeneca shares: Boston Common Asset Management LLC ($25.30M), and Kennedy Capital Management LLC ($5.07M), Eagle Bay Advisors LLC ($156K).Learn more on AstraZeneca's institutional investors. What percentage of AstraZeneca's stock is owned by institutional investors? 40.87% of AstraZeneca's stock is owned by institutional investors. Learn more on AZNCF's institutional investor holdings. Which institutional investors have been buying AstraZeneca's stock? The following institutional investors have purchased AstraZeneca's stock in the last 24 months: Kennedy Capital Management LLC ($37.55K), and Eagle Bay Advisors LLC ($1.00K). Which of AstraZeneca's major shareholders have been selling company stock? The following institutional investors have sold AstraZeneca stock in the last 24 months: Boston Common Asset Management LLC ($79.84K). How much institutional selling is happening at AstraZeneca? Institutional investors have sold a total of 79,838 shares in the last 24 months. This volume of shares sold represents approximately $10.94M in transactions. This page (OTCMKTS:AZNCF) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredApple's secret partnerThe Tiny Company Apple Can’t Live Without A tiny company holds the key to Apple’s biggest breakthrough sinc...The Oxford Club | SponsoredA Worldwide Gold Lockdown Is Now UnderwayCentral banks around the world are hoarding gold at one of the fastest rates in history — and former Goldman S...Stansberry Research | SponsoredBuffett’s Retirement PlayIn 2022, when Larry Benedict called the peak of the market, those who stayed in oil were slaughtered. Meanw...Brownstone Research | SponsoredTrump Issues Surprise Emergency OrderIs This Stock the 'Next Nvidia'? Billionaire Warren Buffett has been loading up on millions of shares of th...Altimetry | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AZNCF Stock Alerts